Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

High-dose pyridoxine and magnesium administration in children with autistic disorder: an absence of salutary effects in a double-blind, placebo-controlled study.

Findling RL, Maxwell K, Scotese-Wojtila L, Huang J, Yamashita T, Wiznitzer M.

J Autism Dev Disord. 1997 Aug;27(4):467-78.

PMID:
9261669
2.

Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study.

Wasserman S, Iyengar R, Chaplin WF, Watner D, Waldoks SE, Anagnostou E, Soorya L, Hollander E.

Int Clin Psychopharmacol. 2006 Nov;21(6):363-7.

PMID:
17012983
3.

Effects of pyridoxine and magnesium on autistic symptoms--initial observations.

Lelord G, Muh JP, Barthelemy C, Martineau J, Garreau B, Callaway E.

J Autism Dev Disord. 1981 Jun;11(2):219-30.

PMID:
6765503
4.

A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder.

Gordon CT, State RC, Nelson JE, Hamburger SD, Rapoport JL.

Arch Gen Psychiatry. 1993 Jun;50(6):441-7.

PMID:
8498878
5.

Risperidone monotherapy in preschool children with pervasive developmental disorders.

Masi G, Cosenza A, Mucci M, De Vito G.

J Child Neurol. 2001 Jun;16(6):395-400.

PMID:
11417603
6.

Risperidone in children with autism: randomized, placebo-controlled, double-blind study.

Nagaraj R, Singhi P, Malhi P.

J Child Neurol. 2006 Jun;21(6):450-5.

PMID:
16948927
7.

Risperidone dosing in children and adolescents with autistic disorder: a double-blind, placebo-controlled study.

Kent JM, Kushner S, Ning X, Karcher K, Ness S, Aman M, Singh J, Hough D.

J Autism Dev Disord. 2013 Aug;43(8):1773-83. doi: 10.1007/s10803-012-1723-5.

PMID:
23212807
8.

The effect of high doses of vitamin B6 on autistic children: a double-blind crossover study.

Rimland B, Callaway E, Dreyfus P.

Am J Psychiatry. 1978 Apr;135(4):472-5.

PMID:
345827
9.

Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months.

Research Units on Pediatric Psychopharmacology Autism Network.

Am J Psychiatry. 2005 Jul;162(7):1361-9.

PMID:
15994720
10.

Clinical and biological effects of high doses of vitamin B6 and magnesium on autistic children.

Lelord G, Callaway E, Muh JP.

Acta Vitaminol Enzymol. 1982;4(1-2):27-44.

PMID:
7124567
11.

Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism.

King BH, Hollander E, Sikich L, McCracken JT, Scahill L, Bregman JD, Donnelly CL, Anagnostou E, Dukes K, Sullivan L, Hirtz D, Wagner A, Ritz L; STAART Psychopharmacology Network.

Arch Gen Psychiatry. 2009 Jun;66(6):583-90. doi: 10.1001/archgenpsychiatry.2009.30.

12.

Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology.

McDougle CJ, Scahill L, Aman MG, McCracken JT, Tierney E, Davies M, Arnold LE, Posey DJ, Martin A, Ghuman JK, Shah B, Chuang SZ, Swiezy NB, Gonzalez NM, Hollway J, Koenig K, McGough JJ, Ritz L, Vitiello B.

Am J Psychiatry. 2005 Jun;162(6):1142-8.

PMID:
15930063
13.

A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism.

Fankhauser MP, Karumanchi VC, German ML, Yates A, Karumanchi SD.

J Clin Psychiatry. 1992 Mar;53(3):77-82.

PMID:
1548248
14.

Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.

Akhondzadeh S, Erfani S, Mohammadi MR, Tehrani-Doost M, Amini H, Gudarzi SS, Yasamy MT.

J Clin Pharm Ther. 2004 Apr;29(2):145-50.

PMID:
15068403
15.

A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders.

McDougle CJ, Holmes JP, Carlson DC, Pelton GH, Cohen DJ, Price LH.

Arch Gen Psychiatry. 1998 Jul;55(7):633-41.

PMID:
9672054
16.
17.

Brief report: lack of response in an autistic population to a low dose clinical trial of pyridoxine plus magnesium.

Tolbert L, Haigler T, Waits MM, Dennis T.

J Autism Dev Disord. 1993 Mar;23(1):193-9. No abstract available.

PMID:
8463199
18.

Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder.

Owen R, Sikich L, Marcus RN, Corey-Lisle P, Manos G, McQuade RD, Carson WH, Findling RL.

Pediatrics. 2009 Dec;124(6):1533-40. doi: 10.1542/peds.2008-3782.

PMID:
19948625
19.

An open clinical trial of risperidone monotherapy in young children with autistic disorder.

Findling RL, Maxwell K, Wiznitzer M.

Psychopharmacol Bull. 1997;33(1):155-9.

PMID:
9133768
20.

[Value of behavior scales and urinary homovanillic acid determinations in monitoring the combined treatment with vitamin B6 and magnesium of children displaying autistic behavior].

Barthélémy C, Garreau B, Leddet I, Sauvage D, Muh JP, Lelord G, Callaway E.

Neuropsychiatr Enfance Adolesc. 1983 May-Jun;31(5-6):289-301. French. No abstract available.

PMID:
6888687

Supplemental Content

Support Center